The username/email didn't match the password, please try again!

Forgot your password?

The email you have inserted is not registered at Medicon Valley Online. If you wish to gain access to a specific organization profile please speak to one of the registered contacts of that organization. The registered contacts can usually be found on the profile page of that organization.

The email you have inserted is not in our database. Plese try again!

To add a compound to a pipeline your organisation needs to be registered as a biotech or pharmaceutical company at Medicon Valley Online. If your organisation is already registered please click on the Sign in button below. If you wish to register a new organisation, please click the Register button.

To add a service your organisation needs to be registered at Medicon Valley Online as a member of Medicon Valley Alliance and have paid the one time fee of 2300 EUR for the service section. If this has been accomplished please, just click the Sign in button below. If you want access to the services section or media about it please send your contact details to contact@mediconvalleyonline.com and we will get back to you.

Email
Password

(Uncheck if on a shared computer)
Forgot your password?
Create Account
Please enter your email address in the field below. Once submitted a message, with an authorization link, will be sent to this address so that you can set a new password for your account. You will have access to you account again in a couple of minutes. Thank you for your patience.
Medicon Valley Online
Home
 
Organisations
 
Drug Pipeline
 
Contract Services
 
Job Market
Filter by: 
Compound Primary Therapeutical Area / Indication Drug development
Balaglitazone Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full full full
Phase III
expand
Liraglutide Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full full full
Phase III
expand
Lixisenatide, Lyxumia® Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full full full
Phase III
expand
Tesofensine Nutritional and Metabolic Diseases / Obesity full full full full
Phase III
expand
LCP-AtorFen Nutritional and Metabolic Diseases / Dyslipidemias full full full
Phase II
expand
LixiLan Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full full
Phase II
expand
Semaglutide Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full full
Phase II
expand
NN1952 Nutritional and Metabolic Diseases / Diabetes Mellitus full full
Phase I
expand
NN9161 Nutritional and Metabolic Diseases / Obesity full full
Phase I
expand
NN9925 Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full
Phase I
expand
PRC-4016 Nutritional and Metabolic Diseases / Dyslipidemias full full
Phase I
expand
SPC4955 Nutritional and Metabolic Diseases / Hypercholesterolemia full full
Phase I
expand
TM38837 Nutritional and Metabolic Diseases / Obesity full full
Phase I
expand
ZP2929 Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full full
Phase I
expand
2hydroxyoleic acid Nutritional and Metabolic Diseases / Obesity full
Pre-clinical
expand
CAM2036 Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full
Pre-clinical
expand
Isosteviol Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full
Pre-clinical
expand
Orph-001 Nutritional and Metabolic Diseases / Lysosomal Storage Diseases full
Pre-clinical
expand
PCSK9 Nutritional and Metabolic Diseases / Hyperlipidemias full
Pre-clinical
expand
TransCon Hydrogel GLP-1 Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 full
Pre-clinical
expand
Pages: 1 2
©2010 Medicon Valley Online - Brought to you by Medicon Valley Alliance. All rights reserved.